Combination of Thrombolysis and Glycoprotein IIb/IIIa Inhibition in Chronic Peripheral Thrombosis: A Case Report
<p>Currently, many interventionalists employ either tissue plasminogen activator (alteplase, Genentech,San Francisco, CA), or recombinant plasminogen activator (reteplase, Chiesi USA, Inc., Cary, NC), for peripheral thrombolysis. Further, combination therapy utilizing a thrombolytic agent and...
שמור ב:
Main Authors: | Mubin I Syed (Author), Ryan Gallagher (Author), Zeshan Hussain (Author), Azim Shaikh (Author), Philip J Cain (Author), Kamal Morar (Author), Matthew Sebastian (Author), Robert Tyrrell (Author), Allen Guehl (Author), Ronald Erdelyi (Author) |
---|---|
פורמט: | ספר |
יצא לאור: |
International Journal of Radiology and Radiation Oncology - Peertechz Publications,
2017-01-24.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
מאת: E. I. Makhiyanova, et al.
יצא לאור: (2016) -
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
מאת: S. B. Fitilev, et al.
יצא לאור: (2022) -
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
מאת: A. S. Tereshchenko, et al.
יצא לאור: (2020) -
Glycoprotein IIIa Preparation for T-cell Stimulation
מאת: GR Anani Sarab, et al.
יצא לאור: (2005) -
Glycoprotein IIIa Preparation for T-cell Stimulation
מאת: GR Anani Sarab, et al.
יצא לאור: (2005)